Category: Accuray Inc.Syndicate content

Accuray CEO: TomoTherapy integration starting to take shape

March 15, 2011 by MassDevice staff

Accuray CEO Euan Thomson outlines the path to integrating recently acquired TomoTherapy in an email to employees.

ARAY logo

Accuray Inc.'s (NSDQ:ARAY) nearly $300 million deal to buy TomoTherapy Inc. (NSDQ:TOMO) isn't closed yet, but the integration of the two companies is already underway.

Accuray CEO Euan Thomson wrote in an email to employees that the company isn't officially beginning the process until the deal closes, but the Sunnyvale, Calif.-based CyberKnife radiosurgery device maker is already taking steps to ensure a smooth transition.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Accuray lines up $277 million TomoTherapy buyout | Acquisitions roundup

March 7, 2011 by MassDevice staff

Accuray Inc. inks an acquisition deal for radiation therapy company TomoTherapy Inc. worth $277 million.

M and A Roundup

Accuray Inc. (NSDQ:ARAY) looks set to acquire radiation treatment firm TomoTherapy Inc. (NSDQ:TOMO) in a deal worth $277 million.

The Sunnyvale, Calif.-based radiosurgery company signed an agreement to buy TomoTherapy for $4.80 per share in cash and stock, a nearly 31 percent premium over its $3.67 closing price on Friday, March 4.

The companies believe their technologies complement one another in that they can serve overlapping patient populations.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Earnings roundup: Thoratec profits leap 58 percent

January 27, 2011 by MassDevice staff

Thoratec Corp. profits jump 58 percent and Accuray Inc. and Cepheid vault out of the red as Abaxis Inc., ResMed Inc., Uroplasty Inc., ZOLL Medical Corp., Solos Endoscopy Inc., Alcon Inc., Cardica Inc. and Omnicell Inc. all release their most recent quarterly sales and earnings numbers.

MassDevice.com Earnings Roundup

MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter's reports.

Here's a quick rundown of a few releases over the past couple days:

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

MassDevice New Year's Special | Euan Thomson

December 27, 2010 by MassDevice staff

Accuray Inc. CEO Euan Thomson: uncertainty in the medical device space will likely remain a constant in 2011.

Euan Thomson

Euan Thomson
CEO, Accuray Inc.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Clearances roundup: Accuray wins 510(k) for CyberKnife lung cancer treatment

December 17, 2010 by Anonymous

A roundup of companies announcing regulatory clearances from the Food & Drug Administration and foreign regulatory agencies.

Clearances roundup

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Accuray wins $1 million from Uncle Sam

October 5, 2010 by MassDevice staff

Accuray Inc. lands a Small Business Innovation Research grant from the U.S. government to develop a high-energy X-ray source for Homeland Security applications.

ARAY logo

The U.S. government awarded Accuray Inc. (NSDQ:ARAY) a $1 million Small Business Innovation Research grant to fund the development of a compact X-ray device for scanning cargo.

The Sunnyvale, Calif.-based radiosurgery device maker has been developing an X-ray device with a high-energy linear accelerator for the Dept. of Homeland Security and completed SBIR-funded research for a prototype in June.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Accuray gives conservative forecast for 2011

August 31, 2010 by MassDevice staff

Sunnyvale, Calif.-based Accuray Inc. predicts flat sales and a break-even year as the company looks to make up a $24 million hole in its revenues.

ARAY logo

Accuray Inc. (NSDQ:ARAY) is starting 2011 with a sizable hole in its top line that will hamper sales growth and profits over the next year, company officials said in a conference call with analysts.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp